Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYHX2011 in Advanced Breast Cancer
NCT06354114Phase 2Not yet recruiting
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Apr 2024
- Primary completion
- Oct 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of SYHX-2011 in breast cancer, sponsored by CSPC Ouyi Pharmaceutical. Primary endpoint: Objective Response Rate. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
SYHX-2011
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06354114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06354114.